Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Neuroone Medical Technologies (NMTC) over the last 13 years, with Q4 2025 value amounting to -$0.03.

  • Neuroone Medical Technologies' EPS (Basic) fell 15000.0% to -$0.03 in Q4 2025 from the same period last year, while for Dec 2025 it was -$0.17, marking a year-over-year increase of 3461.54%. This contributed to the annual value of -$0.09 for FY2025, which is 8048.02% up from last year.
  • Per Neuroone Medical Technologies' latest filing, its EPS (Basic) stood at -$0.03 for Q4 2025, which was down 15000.0% from -$0.04 recorded in Q3 2025.
  • In the past 5 years, Neuroone Medical Technologies' EPS (Basic) ranged from a high of $0.06 in Q4 2024 and a low of -$0.25 during Q2 2021
  • Moreover, its 5-year median value for EPS (Basic) was -$0.12 (2023), whereas its average is -$0.13.
  • As far as peak fluctuations go, Neuroone Medical Technologies' EPS (Basic) surged by 14285.71% in 2024, and later tumbled by 15000.0% in 2025.
  • Neuroone Medical Technologies' EPS (Basic) (Quarter) stood at -$0.18 in 2021, then surged by 38.89% to -$0.11 in 2022, then dropped by 27.27% to -$0.14 in 2023, then surged by 142.86% to $0.06 in 2024, then plummeted by 150.0% to -$0.03 in 2025.
  • Its EPS (Basic) was -$0.03 in Q4 2025, compared to -$0.04 in Q3 2025 and -$0.03 in Q2 2025.